Victory Capital Management Inc Coherus Bio Sciences, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 14,032 shares of CHRS stock, worth $23,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,032

Previous 14,144 0.79%

Holding current value

$23,994

Previous $24,000 41.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$0.99 - $1.8 $110 - $201	-112 Reduced 0.79%	14,032 $14,000
Q2 2024 Aug 05, 2024	BUY	$1.58 - $2.51 $260 - $414	165 Added 1.18%	14,144 $24,000
Q1 2024 May 03, 2024	SELL	$2.02 - $3.14 $660 - $1,026	-327 Reduced 2.29%	13,979 $33,000
Q4 2023 Feb 05, 2024	BUY	$1.59 - $3.85 $5,097 - $12,343	3,206 Added 28.88%	14,306 $47,000
Q3 2023 Nov 06, 2023	SELL	$3.74 - $5.45 $3,889 - $5,668	-1,040 Reduced 8.57%	11,100 $41,000
Q2 2023 Jul 27, 2023	SELL	$3.79 - $8.3 $708 - $1,552	-187 Reduced 1.52%	12,140 $51,000
Q1 2023 May 02, 2023	SELL	$5.89 - $10.52 $16,385 - $29,266	-2,782 Reduced 18.41%	12,327 $84,000
Q4 2022 Feb 09, 2023	SELL	$5.69 - $10.07 $17 - $30	-3 Reduced 0.02%	15,109 $119,000
Q3 2022 Nov 02, 2022	BUY	$7.17 - $13.87 $9,557 - $18,488	1,333 Added 9.67%	15,112 $145,000
Q2 2022 Aug 01, 2022	BUY	$5.86 - $13.23 $2,595 - $5,860	443 Added 3.32%	13,779 $100,000
Q1 2022 May 04, 2022	BUY	$10.92 - $16.41 $145,629 - $218,843	13,336 New	13,336 $121,000
Q4 2021 Feb 07, 2022	SELL	$15.81 - $18.99 $1.54 Million - $1.85 Million	-97,320 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$12.68 - $17.79 $384,939 - $540,068	-30,358 Reduced 23.78%	97,320 $1.56 Million
Q2 2021 Aug 03, 2021	SELL	$12.95 - $15.41 $62,639 - $74,538	-4,837 Reduced 3.65%	127,678 $1.77 Million
Q1 2021 May 04, 2021	BUY	$14.42 - $21.39 $1.65 Million - $2.45 Million	114,668 Added 642.51%	132,515 $1.94 Million
Q4 2020 Feb 01, 2021	BUY	$16.56 - $18.94 $61,884 - $70,778	3,737 Added 26.48%	17,847 $310,000
Q3 2020 Nov 09, 2020	BUY	$17.41 - $19.89 $245,655 - $280,647	14,110 New	14,110 $259,000
Q2 2020 Aug 07, 2020	SELL	$14.43 - $19.16 $146,522 - $194,550	-10,154 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$11.67 - $22.53 $14,587 - $28,162	-1,250 Reduced 10.96%	10,154 $165,000
Q4 2019 Feb 06, 2020	BUY	$16.33 - $21.37 $15,774 - $20,643	966 Added 9.25%	11,404 $205,000
Q4 2019 Feb 04, 2020	BUY	$16.33 - $21.37 $9,389 - $12,287	575 Added 5.83%	10,438 $188,000
Q3 2019 Nov 12, 2019	BUY	$16.3 - $23.37 $160,766 - $230,498	9,863 New	9,863 $200,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $133M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Coherus Bio Sciences, Inc. Transaction History